본문 바로가기
주메뉴 바로가기
뉴로바이오젠
ABOUT
Overview
History
CI
Affiliate Company
This is the way
BUSINESS
Vision & Motto
Pipeline
Tisolagiline(KDS2010)
COMMUNICATIONS
News
Announcements
R&D
Corporate R&D Center
Joint research Institute
IR
Announcement
Corporate Disclosure
CAREERS
Ideal Candidate
Employment Announce
ENG
KOR
ENG
IR
Announcement
Corporate Disclosure
Announcement
[Notice] Legal Proceedings Regarding the Tisolagiline (KDS2010) Technology Transfer Agreement
DATE : 2026-07-10
VIEWS : 34
FILES
[Notice] Legal Proceedings Regarding the Tisolagiline (KDS2010) Technology Transfer Agreement.pdf
Please find attached the notice to shareholders regarding the ongoing legal proceedings related to the Tisolagiline (KDS2010) technology transfer agreement.
For your reference.
Sincerely,
NeuroBiogen Co., Ltd.
PREV
NEXT
Tisolagiline Global Technology Transfer Agreement Announcement
LIST
Add
(06714) 2 FL, Bangbae BLDG, 9, Myeongdal-ro, Seocho-gu, Seoul, Republic of Korea
Tel
+82-70-4018-8009
Fax
+82-02-3486-2613
E-mail
neuro_reply@neurobiogen.com
FAMILY SITE
(주)시너지이노베이션
(주)메디카코리아
(주)프로톡스
(주)인트로바이오파마
(주)엠아이텍
노비스바이오(주)
COPYRIGHT ⓒ 2025 NEUROBIOGEN. All rights reserved